Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implantable device for venous access.

Y E Leclerc, A Loutfi

    Canadian Journal of Surgery. Journal Canadien De Chirurgie
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    The Port-A-Cath device offers an efficient and safe solution for long-term chemotherapy venous access. This study found it well-tolerated by most patients, with manageable complication rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial.

    International journal of surgical oncology·2013
    Same author

    Validation study of the s classification for melanoma patients with positive sentinel nodes: the Montreal experience.

    Annals of surgical oncology·2010
    Same author

    [What is your diagnosis? Severe ischemic colitis with extensive ischemic necrosis of the right colon with perforation and stercoral peritonitis].

    Journal de radiologie·2004
    Same author

    Preliminary Clinical Evaluation of an Instrument for "Positron Emission Mammography" in the Detection of Breast Cancer.

    Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
    Same author

    Positron emission mammographic instrument: initial results.

    Radiology·2001
    Same author

    Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000

    Area of Science:

    • Oncology
    • Medical Devices
    • Surgical Procedures

    Background:

    • Long-term chemotherapy requires reliable venous access.
    • Implantable ports simplify drug administration and blood sampling.

    Purpose of the Study:

    • To evaluate the safety and efficacy of the Port-A-Cath device for venous access in chemotherapy patients.
    • To report initial implantation experiences and complication rates.

    Main Methods:

    • Retrospective review of the first 50 Port-A-Cath implantations.
    • Data collection on patient demographics, indications, operative time, and device performance.
    • Analysis of complication rates including sepsis, blockage, and skin necrosis.

    Main Results:

    Related Experiment Videos

  • Mean operative time was 46.3 minutes via percutaneous subclavian access.
  • Successful blood sampling and infusions reported in 88% and 92% of cases.
  • Overall complication rate was 12% for sepsis, 6% for blockage, and 2% for skin necrosis.

    • Conclusions:

    • The Port-A-Cath is an efficient, safe, and accessible option for long-term chemotherapy.
    • The device demonstrated good patient acceptance and a low rate of serious complications.
    • Careful patient selection and monitoring are crucial to minimize risks like sepsis.